Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Pollack

Showing results (221-230 of 308) with videos related to

Pageof 31
Sort By:
Journal of Neuro-Oncology|June 29, 2016
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium studyRalph Salloum, Trent R Hummel, Shiva Senthil Kumar, et al.
Molecular Oncology|April 4, 2023
Targeting mitochondrial energetics reverses panobinostat- and marizomib-induced resistance in pediatric and adult high-grade gliomasEsther P Jane, Matthew C Reslink, Taylor A Gatesman, et al.
The Journal of Craniofacial Surgery|July 8, 2020
Evaluation of the Patient-Practitioner Consultation on Surgical Treatment Options for Patients With CraniosynostosisKristin D Pfeifauf, Abdullah M Said, Sybill D Naidoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Reply to S.A. UpadhyayaAlyssa T Reddy, Mark D Krailo, Allen B Buxton, et al.
Cancer|October 10, 2013
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022)Jason Fangusaro, Sridharan Gururangan, Tina Young Poussaint, et al.
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
Neuro-Oncology|December 7, 2013
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium studySridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Neuro-Oncology|April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committeeKatherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium StudyMark W Kieran, Roger J Packer, Arzu Onar, et al.
Journal of Translational Medicine|December 21, 2007
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomasHideho Okada, Frank S Lieberman, Kevin A Walter, et al.
Pageof 31

Showing results (221-230 of 308) with videos related to

Sort By:
Pageof 31
Journal of Neuro-Oncology|June 29, 2016
A molecular biology and phase II study of imetelstat (GRN163L) in children with recurrent or refractory central nervous system malignancies: a pediatric brain tumor consortium studyRalph Salloum, Trent R Hummel, Shiva Senthil Kumar, et al.
Molecular Oncology|April 4, 2023
Targeting mitochondrial energetics reverses panobinostat- and marizomib-induced resistance in pediatric and adult high-grade gliomasEsther P Jane, Matthew C Reslink, Taylor A Gatesman, et al.
The Journal of Craniofacial Surgery|July 8, 2020
Evaluation of the Patient-Practitioner Consultation on Surgical Treatment Options for Patients With CraniosynostosisKristin D Pfeifauf, Abdullah M Said, Sybill D Naidoo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2020
Reply to S.A. UpadhyayaAlyssa T Reddy, Mark D Krailo, Allen B Buxton, et al.
Cancer|October 10, 2013
Bevacizumab (BVZ)-associated toxicities in children with recurrent central nervous system tumors treated with BVZ and irinotecan (CPT-11): a Pediatric Brain Tumor Consortium Study (PBTC-022)Jason Fangusaro, Sridharan Gururangan, Tina Young Poussaint, et al.
The Lancet. Oncology|November 8, 2015
Immunotherapy response assessment in neuro-oncology: a report of the RANO working groupHideho Okada, Michael Weller, Raymond Huang, et al.
Neuro-Oncology|December 7, 2013
Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas--a Pediatric Brain Tumor Consortium studySridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Neuro-Oncology|April 28, 2017
Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committeeKatherine E Warren, Gilbert Vezina, Tina Y Poussaint, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2007
Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: a Pediatric Brain Tumor Consortium StudyMark W Kieran, Roger J Packer, Arzu Onar, et al.
Journal of Translational Medicine|December 21, 2007
Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomasHideho Okada, Frank S Lieberman, Kevin A Walter, et al.
Pageof 31